参考文献
1: Sievers P, Uhlmann L, Korkmaz-Icöz S, Fastner C, Bea F, Blessing E, Katus HA, Preusch MR. Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis. Drug Des Devel Ther. 2015 Jul 29;9:3935-42. doi: 10.2147/DDDT.S85203. eCollection 2015. PubMed PMID: 26251572; PubMed Central PMCID: PMC4524379.
2: Nam JH, Oh M, Kim HJ, Han SK, Kim EJ, Song GS, Kim EY, Shin JG, Ghim JL, Kim HS. Pharmacokinetic comparison of amlodipine adipate/valsartan fixed-dose combination with amlodipine besylate/valsartan fixed-dose combination in healthy volunteers. Int J Clin Pharmacol Ther. 2015 Jan;53(1):66-74. doi: 10.5414/CP202045. PubMed PMID: 25034618.
3: Lee SY, Kim JR, Jung JA, Huh W, Bahng MY, Ko JW. Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects. Drug Des Devel Ther. 2015 Jun 2;9:2811-7. doi: 10.2147/DDDT.S82820. eCollection 2015. PubMed PMID: 26082611; PubMed Central PMCID: PMC4459635.
4: Kaur M, Ita KB, Popova IE, Parikh SJ, Bair DA. Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate. Eur J Pharm Biopharm. 2014 Feb;86(2):284-91. doi: 10.1016/j.ejpb.2013.10.007. Epub 2013 Oct 28. PubMed PMID: 24176676.
5: Vojta J, Jedlička A, Coufal P, Janečková L. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form. J Pharm Biomed Anal. 2015 May 10;109:36-44. doi: 10.1016/j.jpba.2015.01.059. Epub 2015 Feb 18. PubMed PMID: 25756663.
6: Shirley M, McCormack PL. Perindopril/amlodipine (Prestalia(®)): a review in hypertension. Am J Cardiovasc Drugs. 2015 Oct;15(5):363-70. doi: 10.1007/s40256-015-0144-1. Review. PubMed PMID: 26341621.
7: Jia T, Zhang LJ, Zhan YQ, Yu JM, Hu DY. [The effectiveness and safety of L-amlodipine besylate for blood pressure control in patients with mild to moderate essential hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Apr;41(4):301-3. Chinese. PubMed PMID: 23906400.
8: Hadžidedić S, Uzunović A, Sehić Jazić S, Kocova El-Arini S. The impact of chirality on the development of robust and stable tablet formulation of (S-) amlodipine besylate. Pharm Dev Technol. 2014 Dec;19(8):930-41. doi: 10.3109/10837450.2013.840847. Epub 2013 Oct 7. PubMed PMID: 24099553.
9: Kim KH, Kim WS. Chronic unilateral chemosis following the use of amlodipine besylate. BMC Ophthalmol. 2014 Oct 21;14:124. doi: 10.1186/1471-2415-14-124. PubMed PMID: 25335530; PubMed Central PMCID: PMC4216336.
10: Salim MM, Ebeid WM, El-Enany N, Belal F, Walash M, Patonay G. Simultaneous determination of aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide in their triple mixture dosage form by capillary zone electrophoresis. J Sep Sci. 2014 May;37(9-10):1206-13. doi: 10.1002/jssc.201301140. Epub 2014 Mar 25. PubMed PMID: 24574149.
11: Choi NY, Choi H, Park HH, Lee EH, Yu HJ, Lee KY, Joo Lee Y, Koh SH. Neuroprotective effects of amlodipine besylate and benidipine hydrochloride on oxidative stress-injured neural stem cells. Brain Res. 2014 Mar 10;1551:1-12. doi: 10.1016/j.brainres.2014.01.016. Epub 2014 Jan 16. PubMed PMID: 24440775.
12: Sharma M, Kothari C, Sherikar O, Mehta P. Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP-HPLC, HPTLC and UV-spectrophotometry. J Chromatogr Sci. 2014 Jan;52(1):27-35. doi: 10.1093/chromsci/bms200. Epub 2013 Jan 4. PubMed PMID: 23293040.
13: Rapolu R, Raju ChK, Srinivas K, Awasthi A, Navalgund SG, Surendranath KV. Isolation and characterization of a novel acid degradation impurity of Amlodipine Besylate using Q-TOF, NMR, IR and single crystal X-ray. J Pharm Biomed Anal. 2014 Oct;99:59-66. doi: 10.1016/j.jpba.2014.07.006. Epub 2014 Jul 15. PubMed PMID: 25072842.
14: Ananchenko G, Novakovic J, Lewis J. Amlodipine besylate. Profiles Drug Subst Excip Relat Methodol. 2012;37:31-77. doi: 10.1016/B978-0-12-397220-0.00002-7. Epub 2012 Mar 19. Review. PubMed PMID: 22469316.
15: Ebeid WM, Elkady EF, El-Zaher AA, El-Bagary RI, Patonay G. Steady-state and synchronous spectrofluorimetric methods for simultaneous determination of aliskiren hemifumarate and amlodipine besylate in dosage forms. Luminescence. 2014 Nov;29(7):878-83. doi: 10.1002/bio.2636. Epub 2014 Mar 31. PubMed PMID: 24687516.
16: Elliott WJ. Rationale for a single-pill combination of perindopril arginine and amlodipine besylate. J Am Soc Hypertens. 2015 Apr;9(4):257-65. doi: 10.1016/j.jash.2014.12.012. Epub 2015 Jan 12. Review. PubMed PMID: 25817217.
17: Rakugi H, Nakata E, Sasaki E, Kagawa T. Evaluation of the efficacy and tolerability of fixed-dose combination therapy of azilsartan and amlodipine besylate in Japanese patients with grade I to II essential hypertension. Clin Ther. 2014 May;36(5):711-21. doi: 10.1016/j.clinthera.2014.03.009. Epub 2014 Apr 16. PubMed PMID: 24742498.
18: Jepson RE, Syme HM, Elliott J. Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate. J Vet Intern Med. 2014 Jan-Feb;28(1):144-53. doi: 10.1111/jvim.12240. Epub 2013 Nov 13. PubMed PMID: 24428319; PubMed Central PMCID: PMC4895535.
19: Özdemir FA, Akyüz A. Simultaneous determination of amlodipine and aliskren in tablets by high-performance liquid chromatography. J Chromatogr Sci. 2014 Aug;52(7):685-90. doi: 10.1093/chromsci/bmt099. Epub 2013 Jul 9. PubMed PMID: 23839804.
20: Belal TS, Mahrous MS, Abdel-Khalek MM, Daabees HG, Khamis MM. Validated spectrofluorimetric determination of two pharmaceutical antihypertensive mixtures containing amlodipine besylate together with either candesartan cilexetil or telmisartan. Luminescence. 2014 Nov;29(7):893-900. doi: 10.1002/bio.2638. Epub 2014 Feb 26. PubMed PMID: 24615878.
